FORT LAUDERDALE, Fla, Nov. 15 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., announced that Eric Milne, MD, FRCR, FRCP, IDSI Director of Clinical Research, has been invited to lecture at the second annual In Vivo Molecular Imaging Conference, November 16-17, in La Jolla, California. Dr. Milne's presentation will focus on human clinical applications.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )
"Molecular imaging has moved very rapidly out of the small animal experimental laboratory environment into the clinical world, assisting in detecting cancer, understanding its development, and following and assessing the value of various cancer treatments," explained Dr. Milne. "The speed with which optical imaging has advanced is well exemplified by the worldwide spread of Computed Tomographic Laser Imaging."
Dr. Milne's presentation, "Clinical Optical Imaging of Breast Cancer," will feature CTLM images from clinical sites in Poland, Germany, Austria, Italy, Turkey, the Middle East and China.
The In Vivo Molecular Imaging Conference is held back-to-back with the Fluorescent Proteins for Cellular Imaging and Drug Development Conference as part of Imaging Week. Both conferences feature panel discussions, scientific poster presentations, and exhibitions.
The CT Laser Mammography (CTLM(R)) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non- invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000-13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems' website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filing with the Securities Exchange Commission.
Investor Relations: Rick Lutz 404-261-1196 lcgroup@mindspring.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comImaging Diagnostic Systems, Inc.CONTACT: Investor Relations, Rick Lutz, +1-404-261-1196, orlcgroup@mindspring.com, for Imaging Diagnostic Systems
Web site: http://www.imds.com/
